Nigrostriatal pathway

Nigrostriatal pathway is a neural pathway that connects the substantia nigra with the dorsal striatum. It is one of the four major dopamine pathways in the brain, and is particularly involved in the production of movement, as part of a system called the basal ganglia motor loop.

Etymology

The term "nigrostriatal" is derived from two Latin words: "nigro", meaning black, and "striatal", referring to the striatum. The substantia nigra is so named because it appears darker than most other brain areas due to high levels of neuromelanin in dopaminergic neurons. The striatum is named for its striped (striated) appearance of gray and white matter.

Anatomy

The nigrostriatal pathway is composed of dopaminergic neurons that originate in the substantia nigra pars compacta (SNc) and project to the dorsal striatum (i.e., the caudate nucleus and the putamen). The striatum also receives input from other parts of the brain, including the cortex and the thalamus.

Function

The nigrostriatal pathway is primarily involved in the regulation of voluntary movement. It is also implicated in reward, reinforcement learning, and habit formation. Dopamine released from the nigrostriatal pathway into the striatum modulates the activity of striatal neurons and influences the output of the basal ganglia motor loop.

Clinical significance

Damage to the nigrostriatal pathway is a major feature of Parkinson's disease, a neurodegenerative disorder characterized by movement problems such as tremor, rigidity, bradykinesia (slowness of movement), and postural instability. The loss of dopaminergic neurons in the substantia nigra and the consequent reduction of dopamine release in the striatum is thought to be the primary cause of the motor symptoms of Parkinson's disease.

See also

• Mesolimbic pathway
• Mesocortical pathway
• Tuberoinfundibular pathway

References

Nigrostriatal pathway Resources
Need Help Finding a Doctor? WikiMD's DocFinder can help find general and specialist physicians.	Latest articles Most recent articles Ongoing trials.